000			01766 a2200553 4500
005			20250512212025.0
264		0	_c19841019
008			198410s 0 0 eng d
022			_a0012-1797
024	7		_a10.2337/diab.33.9.813 _2doi
040			_aNLM _beng _cNLM
100	1		_aLawrence, S
245	0	0	_aFactors influencing reticulophagocytic function in insulin-treated diabetes. _h[electronic resource]
260			_bDiabetes _cSep 1984
300			_a813-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnimals
650	0	4	_aAntigen-Antibody Complex _xanalysis
650	0	4	_aChromium Radioisotopes
650	0	4	_aComplement System Proteins _xanalysis
650	0	4	_aDiabetes Mellitus _xdrug therapy
650	0	4	_aDiabetes Mellitus, Type 1 _xdrug therapy
650	0	4	_aDiabetes Mellitus, Type 2 _xdrug therapy
650	0	4	_aDiabetic Nephropathies _ximmunology
650	0	4	_aDiabetic Retinopathy _ximmunology
650	0	4	_aErythrocytes
650	0	4	_aFemale
650	0	4	_aHLA Antigens _xanalysis
650	0	4	_aHalf-Life
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xanalysis
650	0	4	_aInsulin _xtherapeutic use
650	0	4	_aMacrophages _ximmunology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRabbits
650	0	4	_aReticulocytes _ximmunology
650	0	4	_aSpleen _xblood supply
650	0	4	_aTechnetium
700	1		_aCharlesworth, J A
700	1		_aPussell, B A
700	1		_aCampbell, L V
700	1		_aKotowicz, M A
773	0		_tDiabetes _gvol. 33 _gno. 9 _gp. 813-8
856	4	0	_uhttps://doi.org/10.2337/diab.33.9.813 _zAvailable from publisher's website
999			_c6381087 _d6381087